HCPlive (6/14, Kunzmann) reports, “Antidepressant and sedation therapy trazodone is used frequently for off-label treatment of neuropsychiatric diagnoses including insomnia and anxiety – and infrequently at its indicated dose,” researchers concluded after analyzing data from “1.4 million eligible adults, of whom approximately 310,000 had an insomnia diagnosis and more than half (approximately 170,000) were receiving medical care for the condition.” The findings were presented at the American Psychiatric Association 2022 Annual Meeting.
Related Links:
— “Trazodone Frequently Prescribed in Insomnia Care, Despite Guidelines “Kevin Kunzmann, HCPlive, June 14, 2022